Correction: Tumor immunogenomic signatures improve a prognostic model of melanoma survival

Leah Morales; Danny Simpson; Robert Ferguson; John Cadley; Eduardo Esteva; Kelsey Monson; Vylyny Chat; Carlos Martinez; Jefrey Weber; Iman Osman; Tomas Kirchhof

doi:10.1186/s12967-023-04040-7

Correction: Tumor immunogenomic signatures improve a prognostic model of melanoma survival

J Transl Med. 2023 Mar 31;21(1):234. doi: 10.1186/s12967-023-04040-7.

Authors

Leah Morales^#^{1

2

3}, Danny Simpson^#^{1

2

3}, Robert Ferguson^#^{1

2

3}, John Cadley^{1

2

3}, Eduardo Esteva^{1

2

3}, Kelsey Monson^{1

2

3}, Vylyny Chat^{1

2

3}, Carlos Martinez^{1

2

3}, Jefrey Weber^{1

3

4}, Iman Osman^{1

3

4

5}, Tomas Kirchhof^{6

7

8}

Affiliations

¹ Laura and Isaac Perlmutter Cancer Center, NYU Langone Health, 522 First Avenue, New York City, NY, 10016, USA.
² Departments of Population Health and Environmental Medicine, NYU Langone Health, New York, USA.
³ The Interdisciplinary Melanoma Cooperative Group, NYU Langone Health, New York, USA.
⁴ Department of Medicine, NYU Langone Health, New York, USA.
⁵ Ronald O. Perelman Department of Dermatology, NYU Langone Health, New York, USA.
⁶ Laura and Isaac Perlmutter Cancer Center, NYU Langone Health, 522 First Avenue, New York City, NY, 10016, USA. Tomas.Kirchhof@nyulangone.org.
⁷ Departments of Population Health and Environmental Medicine, NYU Langone Health, New York, USA. Tomas.Kirchhof@nyulangone.org.
⁸ The Interdisciplinary Melanoma Cooperative Group, NYU Langone Health, New York, USA. Tomas.Kirchhof@nyulangone.org.

^# Contributed equally.

No abstract available

Publication types

Published Erratum

Grants and funding

P50 CA225450/CA/NCI NIH HHS/United States